nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

17.10.2022 | Editorial

European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees

verfasst von: Rudi Dierckx, Ken Herrmann, Roland Hustinx, Michael Lassmann, Wolfgang Wadsak, Jolanta Kunikowska

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

The American Society for Radiation Oncology (ASTRO) and the ASTRO board of directors approved in the fall of 2021 a new framework for radiopharmaceutical therapy curriculum development for trainees, which was published by Ana P. Kiess et al. [1]. Being members of the European Association of Nuclear Medicine (EANM) Board, we want to comment officially on behalf of the EANM. …

Kiess AP, Hobbs RF, Bednarz B, Knox SJ, Meredith R, Escorcia FE. ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees. Int J Radiat Oncol Biol Phys. 2022;113(4):719–26. https://doi.org/10.1016/j.ijrobp.2022.03.018.CrossRefPubMed

Goldsmith SJ. Targeted radionuclide therapy: a historical and personal review. Semin Nucl Med. 2020;50:87–97. https://doi.org/10.1053/j.semnuclmed.2019.07.006.CrossRefPubMed

Rowe SP, Pomper MG. Molecular imaging in oncology: current impact and future directions. CA Cancer J Clin. 2022;72(4):333–52. https://doi.org/10.3322/caac.21713.CrossRefPubMed

Bodei L, Herrmann K, Schöder H, Scott AM, Lewis JS. Radiotheranostics in oncology: current challenges and emerging opportunities. Nat Rev Clin Oncol. 2022;19(8):534–50. https://doi.org/10.1038/s41571-022-00652-y.CrossRefPubMed

Herrmann K, Schwaiger M, Lewis JS, Solomon SB, McNeil BJ, Baumann M, et al. Radiotheranostics: a roadmap for future development. Lancet Oncol. 2020;21(3):e146–56. https://doi.org/10.1016/S1470-2045(19)30821-6.CrossRefPubMedPubMedCentral

O Sartor, J de Bono, KN Chi, K Fizazi, K Herrmann, et al for the VISION Investigators¹⁷⁷Lutetium-–PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med 2021; 385. 1091–1103. https://doi.org/10.1056/NEJMoa2107322.

EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. ISBN 978–94–92671–16–5.

Aerts A, Eberlein U, Holm S, Hustinx R, Konijnenberg M, Strigari L, et al. EANM position paper on the role of radiobiology in nuclear medicine. Eur J Nucl Med Mol Imaging. 2021;48:3365–77. https://doi.org/10.1007/s00259-021-05345-9.CrossRefPubMedPubMedCentral

Pouget JP., Konijnenberg M, Eberlein U, Glatting G, Gabina PM, Herrmann K et al, EANM position paper on advancing radiobiology for shaping the future of nuclear medicine. Eur J Nucl Med Mol Imaging 2022; 2022 https://doi.org/10.1007/s00259-022-05934-2.

10.

Herrmann K, Giovanella L, Santos A, Gear J, Kiratli PO, Kurth J, et al. Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre. Eur J Nucl Med Mol Imaging. 2022;49:2300–9. https://doi.org/10.1007/s00259-022-05785-x.CrossRefPubMedPubMedCentral

Titel: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees
verfasst von: Rudi Dierckx
Ken Herrmann
Roland Hustinx
Michael Lassmann
Wolfgang Wadsak
Jolanta Kunikowska
Publikationsdatum: 17.10.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2022
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-022-06011-4

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization

Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients

Regional myocardial perfusion imaging in predicting vessel-related outcome: interplay between the perfusion results and angiographic findings

Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PET

Lymph node classification in E-PSMA reporting guidelines for PSMA-PET

Theranostic application of 64Cu/177Lu-labeled anti-Trop2 monoclonal antibody in pancreatic cancer tumor models